# Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

> **NCT02888223** · PHASE1 · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** SCT800
- **BIOLOGICAL:** Xyntha

## Key facts

- **NCT ID:** NCT02888223
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-02
- **Final completion:** 2017-07
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888223, "Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02888223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*